Previous Article | Next Article 
Journal of Virology, March 2005, p. 3016-3027, Vol. 79, No. 5
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.5.3016-3027.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Immune Tolerance Split between Hepatitis B Virus Precore and Core Proteins
Margaret Chen,1,2
Matti Sällberg,2,3
Janice Hughes,2
Joyce Jones,2
Luca G. Guidotti,4
Francis V. Chisari,4
Jean-Noel Billaud,2 and
David R. Milich2*
Karolinska Institute and Swedish Institute for Infectious Disease Control,1
Division of Clinical Virology, Karolinska Institute at Karolinska University Hospital, Huddinge, Stockholm, Sweden,3
Vaccine Research Institute of San Diego, San Diego,2
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California4
Received 4 August 2004/
Accepted 12 October 2004
The function of the hepatitis B virus (HBV) precore or HBeAg is largely unknown because it is not required for viral assembly, infection, or replication. However, the HBeAg does appear to play a role in viral persistence. It has been suggested that the HBeAg may promote HBV chronicity by functioning as an immunoregulatory protein. As a model of chronic HBeAg exposure and to examine the tolerogenic potential of the HBV precore and core (HBcAg) proteins, HBc/HBeAg-transgenic (Tg) mice crossed with T cell receptor (TCR)-Tg mice expressing receptors for the HBc/HBeAgs (i.e., TCR-antigen double-Tg pairs) were produced. This study revealed three phenotypes of HBe/HBcAg-specific T-cell tolerance: (i) profound T-cell tolerance most likely mediated by clonal deletion, (ii) T-cell clonal ignorance, and (iii) nondeletional T-cell tolerance mediated by clonal anergy and dependent on the structure, location, and concentration of the tolerogen. The secreted HBeAg is significantly more efficient than the intracellular HBcAg at eliciting T-cell tolerance. The split T-cell tolerance between the HBeAg and the HBcAg and the clonal heterogeneity of HBc/HBeAg-specific T-cell tolerance may have significant implications for natural HBV infection and especially for precore-negative chronic hepatitis.
* Corresponding author. Mailing address: Vaccine Research Institute of San Diego, 3030 Bunker Hill St., Suite 300, San Diego, CA 92109. Phone: (858) 581-3960, ext. 226. Fax: (858) 581-3970. E-mail: dmilich{at}vrisd.org.
Journal of Virology, March 2005, p. 3016-3027, Vol. 79, No. 5
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.5.3016-3027.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Depla, E., Van der Aa, A., Livingston, B. D., Crimi, C., Allosery, K., De Brabandere, V., Krakover, J., Murthy, S., Huang, M., Power, S., Babe, L., Dahlberg, C., McKinney, D., Sette, A., Southwood, S., Philip, R., Newman, M. J., Meheus, L.
(2008). Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus Infections. J. Virol.
82: 435-450
[Abstract]
[Full Text]
-
Candotti, D., Danso, K., Allain, J.-P.
(2007). Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. J. Gen. Virol.
88: 2686-2695
[Abstract]
[Full Text]
-
Menne, S., Tennant, B. C., Gerin, J. L., Cote, P. J.
(2007). Chemoimmunotherapy of Chronic Hepatitis B Virus Infection in the Woodchuck Model Overcomes Immunologic Tolerance and Restores T-Cell Responses to Pre-S and S Regions of the Viral Envelope Protein. J. Virol.
81: 10614-10624
[Abstract]
[Full Text]
-
Mancini-Bourgine, M., Bayard, F., Soussan, P., Deng, Q., Lone, Y.-C., Kremsdorf, D., Michel, M.-L.
(2007). Hepatitis B Virus Splice-Generated Protein Induces T-Cell Responses in HLA-Transgenic Mice and Hepatitis B Virus-Infected Patients. J. Virol.
81: 4963-4972
[Abstract]
[Full Text]
-
Yang, G., Liu, A., Xie, Q., Guo, T. B., Wan, B., Zhou, B., Zhang, J. Z.
(2007). Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol
19: 133-140
[Abstract]
[Full Text]
-
Bertoletti, A., Gehring, A. J.
(2006). The immune response during hepatitis B virus infection. J. Gen. Virol.
87: 1439-1449
[Abstract]
[Full Text]
-
Cooper, A., Tal, G., Lider, O., Shaul, Y.
(2005). Cytokine Induction by the Hepatitis B Virus Capsid in Macrophages Is Facilitated by Membrane Heparan Sulfate and Involves TLR2. J. Immunol.
175: 3165-3176
[Abstract]
[Full Text]
Copyright © 2005 by the American Society for Microbiology. All rights reserved.